S
MBOT icon

SignatureFD’s Microbot Medical MBOT Stock Holding History

SignatureFD’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$35 Hold
18
– – ﹤0.01% 3471
2026
Q1 		$43 Hold
18
– – ﹤0.01% 3419
2025
Q4 		$36 Hold
18
– – ﹤0.01% 3347
2025
Q3 		$55 Buy
+18
New +$56 ﹤0.01% 3332

Other funds holding MBOT

AA
AlphaCentric Advisors San Juan, Puerto Rico $118M AUM
LCM
Lazari Capital Management Woodland Hills, California $325M AUM 32.83% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $683M AUM 22.58% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
KPWS
Kestra Private Wealth Services Austin, Texas $9.1B AUM 32.09% 1-Year Est. Return
CA
Cornerstone Advisory Hunt Valley, Maryland $1.21B AUM 19.13% 1-Year Est. Return
BL
BFSG LLC Irvine, California $1.13B AUM 29.95% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
API
Asset Planning Inc Cypress, California $154M AUM 25.18% 1-Year Est. Return

SignatureFD's MBOT Position: Q2 2026 in Review

SignatureFD held its Microbot Medical (MBOT) position steady in Q2 2026 at 18 shares worth $35. The position accounts for ﹤0.01% of the portfolio, ranked #3471.

SignatureFD first reported a position in MBOT in Q3 2025 and has held it in 4 quarters since. The position peaked at $55 in Q3 2025. 19 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • SignatureFD held 18 shares of Microbot Medical worth $35 as of Q2 2026.
  • SignatureFD left its Microbot Medical share count unchanged in Q2 2026.
  • Microbot Medical made up ﹤0.01% of SignatureFD's portfolio in Q2 2026, its #3471 holding.
  • SignatureFD first reported a position in Microbot Medical in Q3 2025 and has held it in 4 quarters since.
  • SignatureFD's Microbot Medical position peaked at $55 in Q3 2025.
  • 19 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.